Kistler-Tiffany Companies’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $79 | Hold |
25
| – | – | ﹤0.01% | 887 |
|
|
2023
Q1 | $111 | Hold |
25
| – | – | ﹤0.01% | 782 |
|
|
2022
Q4 | $166 | Hold |
25
| – | – | ﹤0.01% | 789 |
|
|
2022
Q3 | $0 | Hold |
25
| – | – | ﹤0.01% | 780 |
|
|
2022
Q2 | $0 | Hold |
25
| – | – | ﹤0.01% | 761 |
|
|
2022
Q1 | $1K | Hold |
25
| – | – | ﹤0.01% | 714 |
|
|
2021
Q4 | $1K | Hold |
25
| – | – | ﹤0.01% | 690 |
|
|
2021
Q3 | $3K | Hold |
25
| – | – | ﹤0.01% | 655 |
|
|
2021
Q2 | $2K | Hold |
25
| – | – | ﹤0.01% | 655 |
|
|
2021
Q1 | $3K | Hold |
25
| – | – | ﹤0.01% | 589 |
|
|
2020
Q4 | $2K | Buy |
+25
| New | +$2K | ﹤0.01% | 586 |
|